NCT06205316 - SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

January 22, 2030

Study Completion Date

January 22, 2030

Conditions

Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8

Interventions

DRUG

Antiandrogen Therapy

Receive ADT

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

PROCEDURE

Positron Emission Tomography

Undergo PET scan

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

OTHER

Survey Administration

Ancillary study

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

Trial Locations (6)

54601

NOT_YET_RECRUITING

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

NOT_YET_RECRUITING

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55905

NOT_YET_RECRUITING

Mayo Clinic in Rochester, Rochester

56001

NOT_YET_RECRUITING

Mayo Clinic Health System - Mankato, Mankato

56007

NOT_YET_RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale